Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|January 8, 2026
Opportunity knocking: shared tumor-associated antigen vaccines against global cancer pandemicOlivera FinnPigment Cell & Melanoma Research|March 24, 2009
Highlights from the perspectives in melanoma XII conferenceJohn M Kirkwood, Alexander EggermontCancer Discovery|November 2, 2021
Precision Cancer Medicine: Large Studies Indicate Steady ProgressAlexander Eggermont, Birgit Geoerger, Giuseppe CuriglianoBritish Journal of Cancer|November 11, 2018
PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockadeLaure Hirsch, Laurence Zitvogel, Alexander Eggermont, et al.Oncoimmunology|April 11, 2014
Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumorsAlexander Eggermont, Caroline Robert, Jean Charles Soria, et al.Oncoimmunology|January 27, 2022
LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumorsCamille Jacqueline, Matthew Dracz, Jia Xue, et al.Critical Reviews in Immunology|June 19, 2014
Tumor plasticity interferes with anti-tumor immunitySalem Chouaib, Bassam Janji, Andres Tittarelli, et al.European Journal of Immunology|November 25, 2003
O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cellsFranz-Georg Hanisch, Tilo Schwientek, Michael S Von Bergwelt-Baildon, et al.Cancer Treatment Reviews|August 21, 2003
Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsKeith Wheatley, Natalie Ives, Barry Hancock, et al.Oncoimmunology|March 8, 2014
Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacyStéphane Champiat, Charles Ferté, Sophie Lebel-Binay, et al.Pageof 13